“…First of all, we are delighted about the interest of Baykara et al's group of authors on our novel purification procedure for granulocyte concentrates (GC). 1 So far, the therapeutic use of GC has been reserved for distinct indications. Clinical applicability and usability were limited due to the rapid deterioration in quality caused by enormous lactate production by copious amounts of erythrocytes, resulting in a severely low pH within the first 24 h. The new purification procedure provides multiple advantages by removing contaminations of erythrocytes, platelets and sedimentation agents, thereby providing better storage conditions for leukocytes as well…”